Highest-materiality recent filing
SINTX issues 255K shares, new warrant for 1.27M shares at $2.14
Issued 255,267 shares from abeyance to MedTech Ceramics for no additional consideration.
SINTX raises $5.0M via $4.5M private placement and $0.5M ATM offering
Private placement of 1,882,845 units at $2.39/unit for $4.5M gross proceeds; each unit includes one share and two warrants.
SINTX Technologies receives Nasdaq delisting notice for insufficient stockholders' equity
Received Nasdaq notice on May 22, 2026 for non-compliance with minimum $2.5M stockholders' equity; reported equity ~$904k.
SINTX appoints Ryan Elmore as President, Eric Olson steps down from role effective March 16
Eric Olson ceases as President but remains Chairman and CEO; Ryan Elmore appointed President.
SINTX signs supply agreement with Evonik for SiN/PEEK compound for 3D-printed implants
Evonik Corporation will manufacture SINTX's proprietary SiN/PEEK compound (U.S. Patent No. 10,806,831) at commercial scale.
SINTX Q3 2025 net loss narrows to $3.5M; FDA clearance for SINAPTIC wedge system
Net loss of $3.5M ($1.19 per share) vs $6.2M ($6.96 per share) in Q3 2024.
SINTX Technologies enters $6.4M ATM equity offering agreement with H.C. Wainwright
Aggregate offering price up to $6,413,876; commission rate 3.0% of gross proceeds.
SINTX raises ~$3.8M via warrant exercise inducement; issues new warrants at $4.79 strike
Inducement agreement with holders to exercise 1,099,431 existing warrants at $3.32/share for cash.
SINTX appoints Kevin Trask as CFO; salary $300K, RSUs, bonus eligibility
Kevin Trask appointed CFO effective September 4, 2025; salary set at $300,000 annually.
SINTX submits FDA 510(k) for silicon nitride foot/ankle implants, entering $750M market
Filed 510(k) for silicon nitride osteotomy wedges on July 22, 2025, targeting foot/ankle fusion.
Acquired all IP and designs for six foot/ankle implant systems; market valued at $750M growing to $1.38B by 2032.
SINTX obtains international patent for Si₃N₄ agribiotech use; forms Agribiotech subsidiary
International Patent No. 7635292 covers agricultural uses of silicon nitride (Si₃N₄) for plant protection and antimicrobial treatment.
SINTX refocuses on medical devices; Q1 cash doubles to $6.5M, cash burn halved
Cash on hand $6.5M at March 31, 2025, up from $3.6M at year-end 2024.
SINTX Technologies signs new 2-year exec agreements with CEO Olson and CIO Honigblum
CEO Eric Olson receives $375,000 annual base salary and 40% target bonus; CIO Gregg Honigblum receives $325,000 and 35% target bonus.
SINTX Technologies appoints five new directors; five resign, effective April 3, 2025
Appointed Jay M. Moyes (Audit Chair), Robert D. Mitchell (Nominating & Governance Chair), Mark Anderson (Compensation Chair), Chris Lyons, and Gregg Honigblum (also CSO).
Eric K. Olson appointed Chairman of SINTX Technologies, replacing B. Sonny Bal
Eric K. Olson appointed Chairman of the Board effective March 7, 2025.
SINTX raises $5M in private placement at $3.45/sh with warrants exercisable at $3.32
Gross proceeds of $5.0M from sale of 1,449,287 shares/pre-funded warrants at $3.45 each.
Sintx sells wholly owned subsidiary TA&T to Tethon for liability assumption
Sold all shares of Technology Assessment and Transfer, Inc. to Tethon Corporation on Feb 19, 2025.
Class I director Mark Froimson (MD) elected with 65,138 votes for, 11,650 withheld; 375,417 broker non-votes.
SINTX ups CEO Olson's severance to 2x salary, adds CSO Honigblum change-of-control deal
CEO Eric Olson's severance multiplier raised from 1x to 2x highest annual salary in prior three years.
CEO Eric K. Olson appointed to SINTX Board of Directors effective Nov 22, 2024
Eric K. Olson, CEO and President since August 2024, appointed to the Board of Directors.
SINTX appoints Gregg Honigblum as Chief Strategy Officer; 6-month term, $137,500 base salary
Gregg Honigblum appointed CSO effective Nov 15, 2024; previously Managing Director at FNEX Capital.
SINTX Technologies Announces Stock Repurchase Program of Up to $500,000
Board authorized repurchase of up to $500,000 in common stock, representing about 20% of outstanding shares.
CEO Eric K. Olson's employment term extended from 6 to 12 months, with automatic 6-month renewals unless notice given.
SINTX Technologies enters employment agreement with CEO Eric K. Olson
Six-month term, auto-renewed for six-month periods unless 30 days' notice.
SINTX appoints Eric K. Olson as CEO and President effective August 1, 2024
Eric K. Olson named CEO and President, succeeding B. Sonny Bal who retired as CEO and becomes Chairman.
SINTX Technologies Resumes At-the-Market Equity Offering of Up to $3.1 Million
Company terminated previous ATM sales on March 22, 2024, after raising $15M under original agreement.
SINTX regains Nasdaq minimum bid price compliance; one-year monitoring period begins
Received Nasdaq notice on June 11, 2024 confirming compliance with $1.00 bid price rule.
SINTX announces 1-for-200 reverse stock split effective May 28, 2024 to meet Nasdaq bid price rule
Reverse stock split at 1-for-200 ratio effective May 28, 2024 at 12:01 a.m. ET.
SINTX shareholders approve reverse stock split at ratio 1:100 to 1:300
Special meeting held May 14, 2024; quorum of 24,134,268 shares present.
SINTX Technologies CEO B. Sonny Bal to retire upon naming replacement; remains Chairman
B. Sonny Bal informed board on April 25, 2024 of intent to retire as President and CEO, effective when replacement is named.
Nasdaq notifies SINTX of delisting due to bid price at $0.10 or less for 10 consecutive days
Received delisting notice from Nasdaq on April 8, 2024; bid price closed at $0.10 or less for 10 consecutive days.
SINTX Technologies prices $1.5M public offering of 71.6M shares at $0.021/share
Priced public offering of 71.6M shares at $0.021/share for gross proceeds of ~$1.5M.
SINTX Technologies prices $1.3M public offering of 28.4M shares at $0.047/share
28,400,000 shares priced at $0.047 per share; gross proceeds ~$1.3M.
SINTX receives insurance coverage for furnace damage; expects repair by Q4 2024
Insurance carrier confirms covered loss for sintering furnace that overheated at SINTX Armor in October 2023.
SINTX Technologies prices $4.0M public offering of 16M units at $0.25/unit
Gross proceeds expected ~$4M from 16M units (shares or pre-funded warrants plus Class E & F warrants).
SINTX enters CRADA with U.S. Army Research Lab for 3D printing research
CRADA with U.S. Army Combat Capabilities Development Command Army Research Laboratory.
SINTX reports prelim Q4 rev ~$902k, FY rev $2.6M, up 68% YoY
Q4 2023 revenue approx $902k and full year 2023 revenue $2.6M, both unaudited.
SINTX strengthens antipathogenic patent portfolio with six US and three foreign patents in 2023
Granted six US patents in the last year covering silicon nitride applications: antifungals, antibacterial implants, SARS-CoV-2 inactivation, antiviral compositions, antipathogenic face masks.
SINTX shareholders reject say-on-pay and equity plan increase at 2023 annual meeting
B. Sonny Bal and Jeffrey White elected as Class III directors with 178,101 and 119,145 votes for, respectively.
SINTX enters long-term supply agreement for aerospace jet engine components; revenue <$0.25M/yr
Long-Term Agreement (LTA) to supply silicon nitride jet engine components after 2-year qualification process.
SINTX receives Nasdaq bid price deficiency notice; cure deadline April 2024
Received Nasdaq notice on Oct 20, 2023 due to bid price below $1.00 for 30 consecutive trading days.
SINTX Technologies amends equity distribution agreement with Maxim, extending expiration to Feb 2025
Extends expiration of at-the-market offering facility from Feb 2024 to Feb 25, 2025.
SINTX awarded $1.97M NIH Phase II grant for 3D printed spinal implant
NIH Phase II SBIR grant of $1,972,826 to develop 3D printed silicon nitride-PEEK spinal implant.
SINTX Technologies prices $12M public offering of units with warrants at $5.60/unit
Pricing of 2,150,000 units at $5.60 each; gross proceeds ~$12M before fees.
SINTX prelim Q4 rev $770k, FY22 $1.6M; best annual revenue since 2018
Preliminary unaudited Q4 2022 revenue ~$770k; full year 2022 revenue $1.6M.
SINTX extends ATM equity distribution agreement with Maxim Group through Feb 2024
Amendment extends Distribution Agreement until earlier of $15M sales, 15-day notice termination, or Feb 25, 2024.
SINTX announces 1-for-100 reverse stock split effective Dec 20, 2022
Reverse split ratio set at 1-for-100, effective 12:01 a.m. ET on Dec 20, 2022.
SINTX shareholders approve reverse stock split, elect directors at 2022 annual meeting
Reverse stock split authorized at ratio between 1:10 and 1:100, board to set exact ratio within one year.
SINTX Technologies receives Nasdaq delisting notice over $0.10 rule; seeks hearing
Nasdaq notified SINTX on Nov 17, 2022 that its bid price closed below $0.10 for 10 consecutive days, triggering delisting under Listing Rule 5810(3)(A)(iii).
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
On March 7, 2025, the Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Eric K. Olson to the position of Chairman of the Board of Directors.
In connection with Mr. Olson’s appointment, B. Sonny Bal stepped down as Chairman of the Board and continues to serve on the Company’s Board of Directors.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) has appointed its Chief Executive Officer and President, Eric K. Olson, to the Board of Directors of the Company, effective November 22, 2024.
Gregg Honigblum has been appointed to serve as SINTX Technologies, Inc.’s (the “Company”) Chief Strategy Officer effective November 15, 2024.
On July 31, 2024, the Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Eric K. Olson as Chief Executive Officer and President with such appointment effective August 1, 2024.
In connection with Mr. Olson’s appointment, B. Sonny Bal retired from his position as Chief Executive Officer and President and now serves as Chairman of the Board.
on April 25, 2024, B. Sonny Bal, MD, informed the board of directors of his intention to retire from his position as President and Chief Executive Officer of SINTX Technologies, Inc.
Max materiality 0.85 · Median 0.60 · Most common event other_material